Skip to content
Generated by our own internal defenses, sepsis claims 350,000 adult lives each year in the United States and is the most costly condition behind […]
Battling sepsis and superbugs requires awareness and policy Read More »
Dubbed one of the most significant and inspiring pieces of legislation in the history of innovation and invention in the United States, the Bayh-Dole
Bayh-Dole Coalition awards 5 innovators for groundbreaking discoveries Read More »
Jennifer Camel-Toueg’s son was not getting better. “Alex, who is now 20 years old, was diagnosed with ulcerative colitis at 17,” recalled Camel-Toueg. “With
TrueTrials simplifies finding FDA-authorized cell therapy clinical trials Read More »
The Biotechnology Innovation Organization (BIO) signed a memorandum of understanding (MoU) with Vietnamese state-run pharmaceutical company VinaPharm on September 22, a move that will
BIO, VinaPharm sign MoU to boost cooperation Read More »
As Congress, the U.S. Federal Trade Commission (FTC), and industry are taking a closer look at pharmacy benefit managers (PBMs), a new report highlights
New studies highlight PBMs’ profit sources, customer dissatisfaction Read More »
On September 22, the Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices (ACIP) voted 11-1 to recommend one dose of
More good news for pediatric RSV immunizations Read More »
“The biotech sisterhood is the antidote to the pharma bros,” said Angie You, Ph.D., Chief Executive Officer at Architect Therapeutics, during a lively conversation
Meet the biotech sisterhood—women supporting women in the pharma sector Read More »
With the beginning of respiratory syncytial virus (RSV) season, there is no better time to bring awareness to the efforts going into therapeutic research
Afrobodies’ custom antibodies make use of a unique animal: the alpaca Read More »
Drug price controls in the Inflation Reduction Act (IRA) harm the development of new drugs, according to Sept. 20 testimony in Congress from John
BIO Vice Chair John F. Crowley to Congress: IRA reduces access to innovative drugs Read More »
We need to make progress against the next pandemic, Phyllis Arthur, Senior Vice President of Infectious Diseases & Emerging Science Policy at the Biotechnology
Plan now for next pandemic, BIO’s Phyllis Arthur tells UN preparedness panel Read More »
